
Regeneron's Livsayis (cemdisiran) gains FDA approval for adults with antibody-positive generalized myasthenia gravis, dosed four times a year.
Managing expectations is the new alchemy. All manipulators of opinion, from the US president down to the humblest peddler, now seek to minimize what people expect
almost 26 years ago
Neurology's Broader Promise: An Exclusive Interview with Christopher Reevealmost 26 years ago
The Top Ten Marketing Challenges in Neurologyalmost 26 years ago
Woman With a Mission: Pfizer's Lisa Egbuonu-Davis





